InvestorsHub Logo
Followers 19
Posts 1896
Boards Moderated 0
Alias Born 02/10/2014

Re: None

Wednesday, 03/05/2014 3:53:56 PM

Wednesday, March 05, 2014 3:53:56 PM

Post# of 48316
It would make sense that the partnership will be with the company that has the PD-1/anti-PD-1 that they want to use in the combination 2B study. Thoughts?